Cleaner,,Smart,cashonlycarremovals.com.au,Automatic,/bronchocephalitis837477.html,and,Home Kitchen , Vacuums Floor Care , Vacuums,Robot,$76,Mop,Vacuum,Robotic,Sweeping Robot Vacuum and Mop Cleaner Smart Automatic Arlington Mall Sweeping Robotic $76 Robot Vacuum and Mop Cleaner, Automatic Smart Robotic Sweeping Home Kitchen Vacuums Floor Care Vacuums Robot Vacuum and Mop Cleaner Smart Automatic Arlington Mall Sweeping Robotic $76 Robot Vacuum and Mop Cleaner, Automatic Smart Robotic Sweeping Home Kitchen Vacuums Floor Care Vacuums Cleaner,,Smart,cashonlycarremovals.com.au,Automatic,/bronchocephalitis837477.html,and,Home Kitchen , Vacuums Floor Care , Vacuums,Robot,$76,Mop,Vacuum,Robotic,Sweeping

Robot Large-scale sale Vacuum and Mop Cleaner Smart Automatic Arlington Mall Sweeping Robotic

Robot Vacuum and Mop Cleaner, Automatic Smart Robotic Sweeping

$76

Robot Vacuum and Mop Cleaner, Automatic Smart Robotic Sweeping

|||

Product Description

Robot vacuum mopRobot vacuum mop

Important Tips:

● If you have cables on the floor, please take them away or tape them nicely to decrease the risk of getting stuck.

● Please charge Amrobt at least 6 hours before the first use. Also there is a power switch at the side of Amrobt, Do turn it on to start Amrobt.

● If Amrobt is not used for a long time, please charge it every two months to protect battery.

● Please take care that the bottom anti-drop sensor may be blocked by dust, thus regular cleaning is required.

● Amrobt is not suitable for use in humid environment, such as bathroom, because it would result in internal water ingress or short circuit.

● When Amrobt is used for the first time in a new room, it will automatically enter the edge cleaning mode and scan the room. At this time, it cannot be remotely controlled directly, and can be remotely controlled only after it finishes scanning the room.

Robot Vacuum and Mop Cleaner, Automatic Smart Robotic Sweeping

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA